Zydus Lifesciences bags Doxepin Tablets FDA approval for insomnia
Zydus Lifesciences Limited has secured a pivotal nod from the United States Food and Drug Administration (USFDA) for its Doxepin Tablets, available in 3 mg and 6 mg dosages. These tablets, which correspond to the US Reference Listed Drug (RLD) Silenor Tablets, serve as a remedy for insomnia, aiming to prolong sleep duration and minimize […]